Chemical Structure (Pylarify 01)
Pylarify Injection
Product Images NDC 71258-022
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pylarify (NDC 71258-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Progenics Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (50 mL Vial Label)
PYLARIFY® is an injection used for diagnostic purposes through intravenous use only. It is a sterile non-pyrogenic solution that contains piflufolastat F 18 with an activity range of 37 MBq/ml to 2,960 MBq/ml at End of Synthesis (EOS). It comes in a multiple-dose vial with an expiry time of 10 hours after EOS. The recommended dosage details are available in the prescribing information, and users should calculate the correct dosage from the calibration date and time. It is essential to store PYLARIFY in a shielded container at a controlled temperature range of 20°C to 25°C. The injection contains radioactive material, and users must exercise caution while handling it. Progenics Pharmaceuticals, Inc. manufactures PYLARIFY. The text denotes the product details, usage, composition, and safety procedures required to use it.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
